Edison Pharmaceuticals Inks $20M Series F

Edison Pharmaceuticals has closed a $20 million Series F round, the company announced. Mitsui & Co. Global Investment Inc. led the financing. The money will go toward clinical development of the company’s products.

North AmericaUSBriefs